凱賽生物(688065.SH):Joachim Friedrich Rudolf辭任財務總監
格隆匯1月9日丨凱賽生物(688065.SH)公佈,公司董事會於近期收到公司董事、財務總監Joachim Friedrich Rudolf的書面報吿。Joachim Friedrich Rudolf因個人原因申請辭去公司財務總監職務。Joachim Friedrich Rudolf辭去財務總監職務後,將繼續擔任公司董事、審計委員會委員職務,並擔任公司顧問繼續為公司國際投資併購等相關業務提供諮詢服務。
Joachim Friedrich Rudolf負責的全部工作已進行妥善交接,公司財務副總監楊文穎暫時代行財務總監職責。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.